Breaking News Instant updates and real-time market news.

MIRM

Mirum Pharmaceuticals

$15.00

0.26 (1.76%)

, ITCI

Intra-Cellular

$9.24

0.02 (0.22%)

10:17
08/12/19
08/12
10:17
08/12/19
10:17

Fly Intel: Top five analyst initiations

Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Mirum Pharmaceuticals (MIRM) initiated with an Outperform at Raymond James and Evercore ISI, as well as a Buy at Roth Capital, Citi, and Guggenheim. 2. Intra-Cellular (ITCI) initiated with a Buy at Jefferies. 3. Vicor Corporation (VICR) initiated with a Buy at Craig-Hallum. 4. AssetMark Financial (AMK) initiated with an Outperform at Raymond James, a Buy at Goldman Sachs, a Market Perform at William Blair, and a Neutral at JPMorgan. 5. DTE Energy (DTE) initiated with a Neutral at Mizuho. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.

MIRM

Mirum Pharmaceuticals

$15.00

0.26 (1.76%)

ITCI

Intra-Cellular

$9.24

0.02 (0.22%)

VICR

Vicor Corporation

$29.67

0.66 (2.28%)

AMK

AssetMark Financial

$25.52

-0.78 (-2.97%)

DTE

DTE Energy

$128.99

-0.36 (-0.28%)

  • 12

    Aug

  • 15

    Aug

  • 20

    Aug

  • 21

    Aug

  • 28

    Aug

  • 29

    Aug

  • 27

    Sep

  • 02

    Oct

  • 27

    Dec

MIRM Mirum Pharmaceuticals
$15.00

0.26 (1.76%)

08/12/19
SBSH
08/12/19
INITIATION
Target $21
SBSH
Buy
Mirum Pharmaceuticals initiated with a Buy at Citi
Citi analyst Joel Beatty started Mirum Pharmaceuticals with a Buy rating and $21 price target. The analyst believes maralixibat could potentially be approved by FDA based on its existing data. Data to date validates Maralixibat's mechanism for Alagille syndrome, Beatty tells investors in a research note.
08/12/19
RAJA
08/12/19
INITIATION
Target $28
RAJA
Outperform
Mirum Pharmaceuticals initiated with an Outperform at Raymond James
Raymond James analyst Steven Seedhouse initiated Mirum Pharmaceuticals with an Outperform rating and $28 price target. In a research note to investors, Seedhouse says that despite mixed results in previous maralixibat trials in rare pediatric and adult liver diseases, the most recent datasets for maralixibat in Alagille Syndrome and progressive familial intrahepatic cholestasis suggest maralixibat is effective at reducing bile acids and pruritus and was simply underdosed in prior studies.
08/12/19
ROTH
08/12/19
INITIATION
Target $33
ROTH
Buy
Mirum Pharmaceuticals initiated with a Buy at Roth Capital
Roth Capital analyst Yasmeen Rahimi started coverage of Mirum Pharmaceuticals with a Buy rating and $33 price target. With a successful IPO on July 18, about $175M cash on hand and two Phase 3 trials underway, the analyst believes Mirum is positioned to succeed in the orphan pediatric liver space.
08/12/19
GUGG
08/12/19
INITIATION
Target $18
GUGG
Buy
Guggenheim starts Mirum Pharmaceuticals at Buy with $18 price target
As previously reported, Guggenheim analyst Whitney Ijem initiated Mirum Pharmaceuticals with a Buy rating, citing the view that data so far and the Phase 3 designs for its lead programs for maralixibat for rare pediatric diseases increase their probability of success. The analyst currently models maralix peak sales of about $370M in the indications of Alagille syndrome and progressive familial intrahepatic cholestasis type 2. Ijem set a $18 price target on Mirum shares.
ITCI Intra-Cellular
$9.24

0.02 (0.22%)

08/12/19
JEFF
08/12/19
INITIATION
Target $16
JEFF
Buy
Intra-Cellular initiated with a Buy at Jefferies
Jefferies analyst Andrew Tsai started Intra-Cellular Therapies with a Buy rating and $16 price target. Investor confidence has reached a low point after the FDA recently canceled the company's advisory panel for lumateperone in schizophrenia, Tsai tells investors in a research note. However, the analyst sees a favorable setup at current share levels. He sees upside potential to $20 per share on FDA approval versus downside of $5 per share, or Intra-Cellular's cash position. The likely scenario is a new panel notification in September or October, a positive panel outcome in October or November, and FDA approval on December 27, says Tsai.
12/12/18
12/12/18
NO CHANGE
Target $37

Outperform
Intra-Cellular price target raised to $37 from $35 at RBC Capital
As previously reported, RBC Capital analyst Brian Abrahams raised Intra-Cellular's price target to $37 from $35, saying the FDA NDA acceptance "meaningfully" de-risked the potential for lead drug lumateperone in its most advanced indication, schizophrenia. The analyst also believe shares significantly undervalue lumateperone's potential across neuropsych indications, with potential for bipolar depression data and schizophrenia approval to catalyze upside in 2019. He keeps an Outperform rating on the stock.
07/09/19
RBCM
07/09/19
NO CHANGE
RBCM
Outperform
Intra-Cellular downside looks 'excessive', says RBC Capital
RBC Capital analyst Brian Abrahams kept his Outperform rating on Intra-Cellular, saying the stock downside that followed FDA results from two phase 3 studies of lumateperone in bipolar depression was "excessive". The analyst notes that while study 401 did not demonstrate a meaningful separation from placebo, expectations were low and the "signals of activity" as well as the affirmed clean safety should offer "indirect support" for luma's potential in its other indications such as schizophrenia and depression.
05/23/19
CANT
05/23/19
NO CHANGE
Target $29
CANT
Overweight
Intra-Cellular price target raised to $29 from $26 at Cantor Fitzgerald
Cantor Fitzgerald analyst Charles Duncan raised his price target for Intra-Cellular to $29 from $26 and reiterates an Overweight rating on the shares. Following due diligence, the analyst sees reduced regulatory and commercial risk for lumateperone in its lead indication schizophrenia.
VICR Vicor Corporation
$29.67

0.66 (2.28%)

04/10/19
NORL
04/10/19
INITIATION
Target $36
NORL
Outperform
Vicor Corporation initiated with an Outperform at Northland
Northland analyst Gus Richards initiated Vicor Corporation with an Outperform and $36 price target saying it is a provider of energy efficient power delivery technology with marquee customers including Google, nVidia, and Cray. Vicor's proprietary technology is used to deliver power in the most challenging applications and will benefit from increased use in hyperscale datacenters and AI applications, the analyst wrote in a note to investors.
08/12/19
CHLM
08/12/19
INITIATION
Target $43
CHLM
Buy
Vicor Corporation initiated with a Buy at Craig-Hallum
Craig-Hallum analyst Richard Shannon started coverage of Vicor Corporation with a Buy rating and a $43 price target. The analyst believes sustainable 20%-plus year over year topline growth is possible starting in the second half of 2019 which should drive material EPS growth. Furthermore, Shannon sees potential for the stock to reach $150.
AMK AssetMark Financial
$25.52

-0.78 (-2.97%)

08/12/19
RAJA
08/12/19
INITIATION
Target $31
RAJA
Outperform
AssetMark Financial initiated with an Outperform at Raymond James
Raymond James analyst Patrick O'Shaughnessy initiated AssetMark Financial with an Outperform rating and $31 price target, saying he believes AssetMark's robust growth track record to date highlights both the company's ability to execute as well as the secular tailwinds from which it benefits. As a result, the analyst tells investors in a research note that he believes the company can sustain low double-digit net asset flows and, in the absence of a market selloff, double-digit revenue growth combined with EBITDA margin expansion.
08/12/19
JPMS
08/12/19
INITIATION
Target $29
JPMS
Neutral
AssetMark Financial initiated with a Neutral at JPMorgan
JPMorgan analyst Kenneth Worthington started AssetMark Financial (AMK) with a Neutral rating and $29 price target. While the company has attractive growth prospects, the shares have appreciated 20% from the initial public offering and its valuation is just a 5% discount to closest peer Envestnet (ENV), Worthington tells investors in a research note. The analyst sees the potential for a better entry point.
08/12/19
GSCO
08/12/19
INITIATION
Target $31
GSCO
Buy
AssetMark Financial initiated with a Buy at Goldman Sachs
Goldman Sachs analyst Alexander Blostein initiated AssetMark Financial with a Buy rating and $31 price target, citing its increasing wallet share with existing financial advisors, increasing market share within the Independent Broker/Dealer channel, and the continued secular shift within Wealth Management toward fee-based independent advisors.
08/12/19
WBLR
08/12/19
INITIATION
WBLR
Market Perform
AssetMark Financial initiated with a Market Perform at William Blair
William Blair analyst Chris Shutler started AssetMark Financial with a Market Perform rating due to valuation. The analyst likes the company but prefers to wait for a more opportune time to buy the stock.
DTE DTE Energy
$128.99

-0.36 (-0.28%)

06/04/19
KEYB
06/04/19
INITIATION
Target $136
KEYB
Overweight
DTE Energy initiated with an Overweight at KeyBanc
KeyBanc analyst Sophie Karp started DTE Energy with an Overweight rating and $136 price target. The analyst likes the company's "strong" utility growth and track record of "constructive" regulatory outcomes in its core territories.
08/12/19
MZHO
08/12/19
INITIATION
MZHO
Neutral
DTE Energy initiated with a Neutral at Mizuho
Mizuho analyst Anthony Crowdell started DTE Energy with a Neutral rating and $131 price target. The analyst views the company's growth opportunities in Michigan as attractive but he finds the stock fairly valued at current levels.
01/17/19
01/17/19
INITIATION

Fly Intel: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Tencent Music (TME) initiated with an Overweight at JPMorgan. 2. Craft Brew (BREW) initiated with a Buy at Maxim while Castle Brands (ROX) was initiated with a Hold. 3. CVS Health (CVS) and LabCorp (LH) were initiated with a Buy at UBS while Walgreens Boots Alliance (WBA) was initiated with a Sell. 4. DTE Energy (DTE) initiated with a Buy at Goldman Sachs while CMS Energy (CMS) was initiated with a Neutral. 5. Zendesk (ZEN) and HubSpot (HUBS) were initiated with an Overweight at Stephens while Adobe (ADBE) was initiated with an Equal Weight. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
07/19/19
MKMP
07/19/19
NO CHANGE
Target $17
MKMP
Buy
Adtran price target lowered to $17 from $20 at MKM Partners
MKM Partners analyst Michael Genovese lowered his price target on Adtran (ADTN) to $17, saying the company's latest earnings report was a "setback" for the company. The analyst says the stock has become a "show-me" story given its the review of its "accounting practices to determine excess and obsolete inventory reserves" and may prompt restatements. Genovese is also concerned with Adtran's weak Q3 revenue guidance amid an infrastructure spending pause of Deutsche Telecom (DTE). The analyst still maintains his Buy rating on Adtran, citing its broadband access deployment opportunities with the two largest U.S. telcos.

TODAY'S FREE FLY STORIES

CMCSA

Comcast

$43.17

0.82 (1.94%)

, AEO

American Eagle

$15.40

0.63 (4.27%)

19:34
08/18/19
08/18
19:34
08/18/19
19:34
Hot Stocks
Fly Intel: Top five weekend stock stories »

Catch up on the…

CMCSA

Comcast

$43.17

0.82 (1.94%)

AEO

American Eagle

$15.40

0.63 (4.27%)

MO

Altria Group

$46.48

1 (2.20%)

CMCSK

Comcast

$0.00

(0.00%)

GO

Grocery Outlet

$46.55

2.81 (6.42%)

RDS.B

Royal Dutch Shell

$55.56

0.46 (0.83%)

RDS.A

Royal Dutch Shell

$55.55

0.47 (0.85%)

BP

BP

$36.27

0.22 (0.61%)

XOM

Exxon Mobil

$68.30

1.06 (1.58%)

MYGN

Myriad Genetics

$25.36

2.14 (9.22%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Aug

  • 04

    Sep

  • 25

    Sep

  • 25

    Sep

  • 27

    Oct

  • 13

    Nov

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$288.79

4.12 (1.45%)

19:27
08/18/19
08/18
19:27
08/18/19
19:27
Periodicals
Trump does not want to do business with Huawei, Reuters reports »

President Donald Trump…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$288.79

4.12 (1.45%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XYF

X Financial

$2.61

0.04 (1.56%)

19:25
08/18/19
08/18
19:25
08/18/19
19:25
Earnings
X Financial reports Q2 EPS 31c, consensus 22c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Aug

VJET

Voxeljet

$1.64

-0.05 (-2.96%)

18:44
08/18/19
08/18
18:44
08/18/19
18:44
Recommendations
Voxeljet analyst commentary at Piper Jaffray »

Voxeljet price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SSNLF

Samsung

$0.00

(0.00%)

, AAPL

Apple

$206.44

4.71 (2.33%)

18:40
08/18/19
08/18
18:40
08/18/19
18:40
Periodicals
Apple CEO warns Trump about China tariffs, Reuters reports »

President Donald Trump…

SSNLF

Samsung

$0.00

(0.00%)

AAPL

Apple

$206.44

4.71 (2.33%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Oct

T

AT&T

$34.98

0.64 (1.86%)

, CMCSA

Comcast

$43.17

0.82 (1.94%)

18:05
08/18/19
08/18
18:05
08/18/19
18:05
On The Fly
Box Office Battle: 'Good Boys' wins weekend with $21M debut »

"Box Office Battle" is…

T

AT&T

$34.98

0.64 (1.86%)

CMCSA

Comcast

$43.17

0.82 (1.94%)

CMCSK

Comcast

$0.00

(0.00%)

SNE

Sony

$55.72

0.64 (1.16%)

LGF.A

Lionsgate

$11.06

0.02 (0.18%)

LGF.B

Lionsgate

$10.52

0.01 (0.10%)

DIS

Disney

$135.19

1.79 (1.34%)

VIAB

Viacom

$26.02

0.09 (0.35%)

VIA

Viacom

$27.27

-0.4 (-1.45%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Sep

  • 23

    Oct

  • 27

    Oct

SFTBF

SoftBank

$0.00

(0.00%)

, SFTBY

SoftBank

$0.00

(0.00%)

17:59
08/18/19
08/18
17:59
08/18/19
17:59
Periodicals
Softbank plans to lend up to $20B to employees to invest in new fund, WSJ says »

Softbank is planning to…

SFTBF

SoftBank

$0.00

(0.00%)

SFTBY

SoftBank

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$288.79

4.12 (1.45%)

16:50
08/18/19
08/18
16:50
08/18/19
16:50
Periodicals
Trump administration to give Huawei more time to work with U.S. clients,WSJ says »

The Trump administration…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$288.79

4.12 (1.45%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JSAIY

J Sainsbury

$0.00

(0.00%)

16:46
08/18/19
08/18
16:46
08/18/19
16:46
Periodicals
J Sainsbury's not talking to internal candidates for CEO succession,Reuters says »

J Sainsbury's is not…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TSLA

Tesla

$219.92

4.27 (1.98%)

16:39
08/18/19
08/18
16:39
08/18/19
16:39
Hot Stocks
Tesla relaunching solar-panel business with no-contract rentals »

Tesla is now offering…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Sep

  • 23

    Sep

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$288.79

4.12 (1.45%)

16:14
08/18/19
08/18
16:14
08/18/19
16:14
Periodicals
White House says no recession in sight, Reuters reports »

White House officials…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$288.79

4.12 (1.45%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVS

Novartis

$89.46

0.91 (1.03%)

16:11
08/18/19
08/18
16:11
08/18/19
16:11
Periodicals
Novartis executive sold shares before data manipulation made public,Reuters says »

An unnamed Novartis…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

  • 25

    Sep

MO

Altria Group

$46.48

1 (2.20%)

16:08
08/18/19
08/18
16:08
08/18/19
16:08
Periodicals
CDC investigating lung illness linked to e-cigarette use, Reuters reports »

The Centers for Disease…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CFB

CrossFirst Bancshares

$14.61

(0.00%)

, JFU

9F Inc

$10.09

0.52 (5.43%)

08:48
08/18/19
08/18
08:48
08/18/19
08:48
On The Fly
Opening Day: CrossFirst rises after setting IPO share price lower than expected »

Shares of CrossFirst…

CFB

CrossFirst Bancshares

$14.61

(0.00%)

JFU

9F Inc

$10.09

0.52 (5.43%)

NET

Cloudflare

$0.00

(0.00%)

WE

We Company

$0.00

(0.00%)

SDC

SmileDirectClub

$0.00

(0.00%)

AMZN

Amazon.com

$1,791.82

16.72 (0.94%)

MSFT

Microsoft

$136.13

2.39 (1.79%)

SFTBF

SoftBank

$0.00

(0.00%)

SFTBY

SoftBank

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Sep

  • 10

    Sep

  • 27

    Oct

CBS

CBS

$43.83

0.5 (1.15%)

, VIA

Viacom

$27.27

-0.4 (-1.45%)

08:03
08/17/19
08/17
08:03
08/17/19
08:03
Periodicals
Viacom-CBS merger got panned by investors, Barron's says »

CBS (CBS) and Viacom…

CBS

CBS

$43.83

0.5 (1.15%)

VIA

Viacom

$27.27

-0.4 (-1.45%)

VIAB

Viacom

$26.02

0.09 (0.35%)

AAPL

Apple

$206.44

4.71 (2.33%)

DIS

Disney

$135.19

1.79 (1.34%)

T

AT&T

$34.98

0.64 (1.86%)

CMCSA

Comcast

$43.17

0.82 (1.94%)

CMCSK

Comcast

$0.00

(0.00%)

NFLX

Netflix

$302.74

6.81 (2.30%)

AMZN

Amazon.com

$1,791.82

16.72 (0.94%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Sep

  • 05

    Sep

  • 23

    Sep

  • 23

    Oct

  • 27

    Oct

MYGN

Myriad Genetics

$25.36

2.14 (9.22%)

07:57
08/17/19
08/17
07:57
08/17/19
07:57
Periodicals
Myriad Genetics stock might have an FDA issue, Barron's says »

Myriad Genetics plunged…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

CSCO

Cisco

$46.96

0.73 (1.58%)

, NTAP

NetApp

$46.75

0.33 (0.71%)

07:50
08/17/19
08/17
07:50
08/17/19
07:50
Periodicals
Trade war hitting tech stocks, Barron's says »

Cisco (CSCO) plunged 9% a…

CSCO

Cisco

$46.96

0.73 (1.58%)

NTAP

NetApp

$46.75

0.33 (0.71%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Sep

  • 12

    Sep

  • 10

    Oct

  • 13

    Nov

RDS.A

Royal Dutch Shell

$55.55

0.47 (0.85%)

, RDS.B

Royal Dutch Shell

$55.56

0.46 (0.83%)

07:47
08/17/19
08/17
07:47
08/17/19
07:47
Periodicals
Investors should not abandon oil, gas stocks, Barron's says »

Energy stocks have rarely…

RDS.A

Royal Dutch Shell

$55.55

0.47 (0.85%)

RDS.B

Royal Dutch Shell

$55.56

0.46 (0.83%)

BP

BP

$36.27

0.22 (0.61%)

XOM

Exxon Mobil

$68.30

1.06 (1.58%)

CVX

Chevron

$115.79

0.08 (0.07%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Aug

  • 25

    Sep

TGT

Target

$84.20

1.67 (2.02%)

, WMT

Walmart

$112.99

0.32 (0.28%)

07:40
08/17/19
08/17
07:40
08/17/19
07:40
Periodicals
Grocery Outlet thriving as rivals struggle, Barron's says »

While Dow was down 800…

TGT

Target

$84.20

1.67 (2.02%)

WMT

Walmart

$112.99

0.32 (0.28%)

GO

Grocery Outlet

$46.55

2.81 (6.42%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

  • 15

    Sep

  • 19

    Sep

  • 25

    Sep

  • 13

    Nov

  • 14

    Nov

AEO

American Eagle

$15.40

0.63 (4.27%)

07:33
08/17/19
08/17
07:33
08/17/19
07:33
Periodicals
American Eagle to soar despite trade war, Barron's says »

American Eagle's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Sep

  • 25

    Sep

ANGI

Angi Homeservices

$8.18

-0.18 (-2.15%)

, MTCH

Match Group

$84.53

2.08 (2.52%)

07:27
08/17/19
08/17
07:27
08/17/19
07:27
Periodicals
Dating business might be IAC's best asset, greatest challenge, Barron's says »

IAC (IAC) has rallied 34%…

ANGI

Angi Homeservices

$8.18

-0.18 (-2.15%)

MTCH

Match Group

$84.53

2.08 (2.52%)

IAC

IAC

$249.17

4.21 (1.72%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Sep

  • 10

    Sep

  • 10

    Oct

AAPL

Apple

$206.44

4.71 (2.33%)

, HAS

Hasbro

$114.29

1.13 (1.00%)

07:13
08/17/19
08/17
07:13
08/17/19
07:13
On The Fly
Week in review How Trump's policies moved stocks »

Catch up on the top…

AAPL

Apple

$206.44

4.71 (2.33%)

HAS

Hasbro

$114.29

1.13 (1.00%)

MAT

Mattel

$10.74

(0.00%)

AGR

Avangrid

$49.29

0.37 (0.76%)

JPM

JPMorgan

$107.73

2.52 (2.40%)

BAC

Bank of America

$27.04

0.79 (3.01%)

C

Citi

$63.46

2.13 (3.47%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Sep

  • 09

    Sep

  • 02

    Oct

  • 15

    Oct

  • 15

    Oct

  • 16

    Oct

  • 27

    Oct

NCLH

Norwegian Cruise Line

$50.48

1.38 (2.81%)

18:04
08/16/19
08/16
18:04
08/16/19
18:04
Hot Stocks
Norwegian Cruise Line CEO sells 25K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RM

Regional Management

$27.12

0.14 (0.52%)

18:01
08/16/19
08/16
18:01
08/16/19
18:01
Hot Stocks
Regional Management CFO buys 5K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

RTN

Raytheon

$178.10

-0.42 (-0.24%)

17:59
08/16/19
08/16
17:59
08/16/19
17:59
Hot Stocks
Raytheon awarded $199.59M Navy contract for MK 15 CIWS »

Raytheon has been awarded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.